The Bio Report
Levine Media Group
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Episodes (1239)
Advocating for the Extension of Healthy Life
The Bio Report
Using Donated Living Skin as an Alternative to Animal Testing
The Bio Report
A Platform to Scale the Production of Personalized Cell Therapies
The Bio Report
Developing Small Molecule Therapies to Target Proteins Only Biologics Have Been...
The Bio Report
Targeting Solid Tumors with Oncolytic Viruses
The Bio Report
Reinventing the Discovery and Cell Line Development of Biotherapeutics
The Bio Report
Engineering Off-the-Shelf Cell Therapies to Target Solid Tumors
The Bio Report
Democratizing Drug Discovery
The Bio Report
Scaling Genetic Counseling Services with AI
The Bio Report
Programming Cell Therapies to Overcome Solid Tumor Defense Systems
The Bio Report
Using Liquid Biopsies to Diagnose Infectious Diseases
The Bio Report
Striking Hepatitis B at Its Core
The Bio Report
Modulating Serotonin with Psychedelics to Treat Neuropsychiatric Conditions
The Bio Report
A Procedural Therapy Seeks to Address Type 2 Diabetes at Its Root Cause
The Bio Report
Building a Better Path to Neurotherapeutics
The Bio Report
Taking a Portfolio Approach to Immuno-Oncology
The Bio Report
Engineering Life to Reach New Worlds
The Bio Report
Targeting Cancer Drug Side Effects at Their Source
The Bio Report
Mapping the Universe of Human Proteins
The Bio Report
Fighting Disease by Modulating the Translation of Proteins
The Bio Report
Fixing Biopharma’s R&D Productivity by Taking a Cue from the Tech Industry
The Bio Report
An Affordable and Widely Available Drug Offers Global Hope against COVID
The Bio Report
A Gene Therapy to Program the Body to Produce a Treatment for Osteoarthritis
The Bio Report
A Test for Data-Driven Drug Development
The Bio Report
Bridging the Gulf Between the Promise and Reality of Precision Health
The Bio Report
Using Synthetic Biology to Craft One-Time, Programmable mRNA Therapeutics
The Bio Report
Using a Digital Cognitive Behavior Therapy to Treat Diabetes and Heart Disease
The Bio Report
Disrupting Pain Signals with Precision
The Bio Report
A Diagnostics Company Moves to Developing Precision Cancer Therapies
The Bio Report
Characterizing the Immunome at Scale
The Bio Report
Delivering Oxygen to Tissue in Need
The Bio Report
Using Gene Therapy to Create a Drug Biofactory within a Patient
The Bio Report
Finding New Uses for TNF Inhibitors
The Bio Report
Using AI to Map the Undiscovered World of Bioactive Compounds in Plants
The Bio Report
Improving the Delivery of Drugs through Thin Film Freezing
The Bio Report
Using CRISPR to Target RNA Instead of DNA
The Bio Report
An Antisense Pioneer Brings Custom Treatments to Patients with Ultra-Rare Condit...
The Bio Report
Managing Neurodegenerative Diseases with Better Data to Improve Outcomes
The Bio Report
A Small Molecule Cancer Drug That Promotes an Adaptive Immune Response
The Bio Report
Sloan-Kettering Spin-Out Harnesses AI to Diagnose Cancer
The Bio Report
Bringing Innovation to Cell and Gene Therapy Manufacturing
The Bio Report
Tapping Psychedelics for their Anti-Inflammatory Powers
The Bio Report
Advancing Cell Therapies Beyond Cancer
The Bio Report
How the Pandemic Transformed a Small Diagnostics Company
The Bio Report
Eliminating Security, Privacy, and Regulatory Burdens with Synthetic Data
The Bio Report
Using Computational Discovery to Build Better Immunotherapies
The Bio Report
The Year in Biotech and What’s Ahead in 2021
The Bio Report
Bringing Precision Cancer Care to Dogs
The Bio Report
As COVID-19 Vaccines Ship, One Company Brings Innovation to the Vials
The Bio Report
Advancing an Antibody to Prevent and Treat Cytokine Storms in COVID-19
The Bio Report